- Home
- RVPH vs STRM Comparison
RVPH vs STRM Comparison
Compare RVPH & STRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- STRM
- Stock Information
- Founded
- RVPH 2006
- STRM 1989
- Country
- RVPH United States
- STRM United States
- Employees
- RVPH N/A
- STRM N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- STRM EDP Services
- Sector
- RVPH Health Care
- STRM Technology
- Exchange
- RVPH Nasdaq
- STRM Nasdaq
- Market Cap
- RVPH 26.6M
- STRM 22.3M
- IPO Year
- RVPH N/A
- STRM 1996
- Fundamental
- Price
- RVPH $0.47
- STRM $5.31
- Analyst Decision
- RVPH Strong Buy
- STRM
- Analyst Count
- RVPH 5
- STRM 0
- Target Price
- RVPH $9.00
- STRM N/A
- AVG Volume (30 Days)
- RVPH 3.4M
- STRM 29.2K
- Earning Date
- RVPH 08-13-2025
- STRM 09-10-2025
- Dividend Yield
- RVPH N/A
- STRM N/A
- EPS Growth
- RVPH N/A
- STRM N/A
- EPS
- RVPH N/A
- STRM N/A
- Revenue
- RVPH N/A
- STRM $18,381,000.00
- Revenue This Year
- RVPH N/A
- STRM $18.64
- Revenue Next Year
- RVPH N/A
- STRM N/A
- P/E Ratio
- RVPH N/A
- STRM N/A
- Revenue Growth
- RVPH N/A
- STRM N/A
- 52 Week Low
- RVPH $0.30
- STRM $1.82
- 52 Week High
- RVPH $4.28
- STRM $9.45
- Technical
- Relative Strength Index (RSI)
- RVPH 47.70
- STRM 79.00
- Support Level
- RVPH $0.38
- STRM $5.27
- Resistance Level
- RVPH $0.45
- STRM $5.31
- Average True Range (ATR)
- RVPH 0.03
- STRM 0.03
- MACD
- RVPH 0.02
- STRM -0.05
- Stochastic Oscillator
- RVPH 93.07
- STRM 89.29
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.